Hepatitis C NS5B polymerase inhibitors: functional equivalents for the benzothiadiazine moiety.
A series of quinoline derivatives was synthesized as potential bioisosteric replacements for the benzothiadiazine moiety of earlier Hepatitis C NS5B polymerase inhibitors. Several of these compounds exhibited potent activity in enzymatic and replicon assays.